How should I document a bilateral lower extremity double amputee in the medical record?

Documentation of Bilateral Lower Extremity Amputation

Document bilateral lower extremity amputation by clearly specifying the level of amputation for each limb (e.g., "bilateral below-knee amputation" or "bilateral transtibial amputation"), the etiology (traumatic vs. dysvascular/diabetic), date of each amputation if different, and current functional status including prosthetic use and ambulatory ability.

Essential Documentation Elements

When charting a bilateral lower extremity amputee, your documentation should include:

Amputation Level Specification

• Precise anatomic level for each limb: Use standardized terminology such as:
  • Transtibial (below-knee)
  • Transfemoral (above-knee)
  • Knee disarticulation
  • Hip disarticulation
  • Partial foot (specify: transmetatarsal, Chopart, Lisfranc, toe amputation)
• Document if levels differ between limbs (e.g., "right transtibial, left transfemoral")

Etiology and Timing

• Primary cause: Dysvascular disease, diabetes, trauma, infection, or other
• Date of each amputation: Critical for tracking progression, especially in dysvascular disease where 55% of diabetic patients with dysvascular disease undergo contralateral limb amputation within 2-3 years 1
• Circumstances: Primary amputation (life-threatening situation) vs. secondary amputation (failed revascularization)

Functional Status Documentation

The 2024 ACC/AHA guidelines emphasize that walking with prosthesis and prosthetic use are the two outcomes with the greatest impact on quality of life among amputees 2. Therefore, document:

• Current ambulatory status: Independent ambulation, assisted ambulation, wheelchair-dependent, or bedbound
• Prosthetic use: Type of prosthesis for each limb, frequency of use, and functional level achieved
• Living situation: Home vs. facility (impacts QOL) 2

Clinical Context for Ongoing Care

Document factors that influence prognosis and care planning, as bilateral amputees face amplified challenges compared to single-limb loss 1:

Risk factors affecting outcomes 2:

• Age (>65 years associated with lower QOL)
• Diabetes presence
• Social isolation/homebound status
• Timing and quality of postamputation support

Ongoing care needs:

• Pain management status (phantom limb pain, residual limb pain)
• Wound healing status if recent amputation
• Need for multispecialty team involvement 2
• Behavioral health considerations 1

Documentation Template Structure

A complete chart entry should follow this format:

"Bilateral lower extremity amputee: [Right/Left level] and [Right/Left level], secondary to [etiology], performed [dates]. Currently [ambulatory status] with [prosthetic details]. Lives [home/facility]. [Relevant comorbidities: diabetes, age >65, etc.]"

Example:

"Bilateral transtibial amputee: right transtibial amputation 03/2022, left transtibial amputation 08/2023, both secondary to diabetic peripheral artery disease with chronic limb-threatening ischemia. Currently ambulates independently with bilateral prostheses for household distances. Lives at home with spouse. Diabetes present, age 68 years."

Common Pitfalls to Avoid

• Vague terminology: Avoid terms like "double amputee" or "BKA x2" without specifying exact levels
• Omitting etiology: Critical for understanding risk of progression and guiding preventive care
• Failing to document functional status: This is the primary determinant of QOL and guides rehabilitation planning 2, 3
• Not tracking timing: Especially important in dysvascular disease for monitoring contralateral limb risk 1
• Ignoring psychosocial factors: Social isolation and living situation significantly impact outcomes 2

Special Considerations for Dysvascular Amputees

For patients with dysvascular disease (>80% of new amputations in the US) 1, additional documentation should include:

• Contralateral limb status: Presence of peripheral artery disease, wounds, or ischemia
• Vascular risk factor control: Diabetes management, lipid control (LDL-C <55 mg/dL target), antiplatelet therapy 4
• Annual surveillance: Document need for ongoing vascular assessment 4

The 2024 guidelines recommend customized follow-up care programs including local wound care, pressure offloading, serial foot biomechanics evaluation, and therapeutic footwear to prevent wound recurrence 2, which should be referenced in ongoing documentation.